News | PACS Accessories | March 12, 2018

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018

New digital offerings include solutions for image analysis, PAMA compliance assistance, laboratory performance optimization and more

Siemens Healthineers Launches New Partners for Digital Ecosystem at HIMSS 2018

March 12, 2018 — At the 2018 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition, March 5-9 in Las Vegas, Siemens Healthineers showcased new additions and updates to its Digital Ecosystem,1 an open and secured environment for healthcare stakeholders that houses a range of digital offerings from Siemens Healthineers and other partners based on shared healthcare data. Within the Siemens Healthineers cloud, different data sources can be integrated and processed, supporting a large variety of application types. To date, almost 2,000 institutions from roughly 50 countries take part in the Digital Ecosystem, continuously feeding data into this platform to derive insights based on innovative applications and services.

At HIMSS 2018, Siemens Healthineers unveiled a number of new partners and applications:

  • Amra Medical: An international digital health company, it is the first in the world to transform images from a rapid, six-minute whole body magnetic resonance imaging (MRI) scan into precise, 3-D-volumetric fat and muscle measurements, enabling high accuracy and precision when assessing lean tissue changes, muscle fat infiltration, and overall metabolic status;
  • Circle: Circle Cardiovascular Imaging Inc. develops cvi42, a cardiovascular post-processing software for the analysis of MRI and computed tomography (CT) images, providing rapid analysis with high accuracy;
  • Combinostics: Combinostics’ cNeuro cMRI application turns MRI brain images into objective measurements of brain structures, supporting early diagnosis in Alzheimer’s disease and other neurodegenerative diseases;
  • Cranberry Peak: Approved by the Centers for Medicare & Medicaid Services (CMS) for the Appropriate Use Criteria Program, Cranberry Peak’s ezCDS application provides compliance with ease for Protecting Access to Medicare Act (PAMA)/Medicare Access and CHIP Reauthorization Act (MACRA) mandates with a patent-pending artificial intelligence (AI) assistant serving as a clinical decision support (CDS) mechanism. With multilingual voice and conversational interface, ezCDS helps physicians spend more time with patients and less with computer screens, creating the user experience of the future in healthcare;
  • Precision Image Analysis (PIA): PIA is a service provider of cloud-based, advanced medical image post-processing and analysis. PIA offers an opportunity to avoid training personnel, software and hardware capital costs and employ an on-demand post-processing expert. Completed analyses are returned and auto-appended to original patient studies on the client’s picture archiving and communication system (PACS) for final diagnostic interpretation by the physician; and
  • XIFIN: XIFIN is the first partner to offer solutions for the clinical laboratory on the Siemens Healthineers Digital Ecosystem. Their flagship cloud-based revenue cycle management (RCM) solution optimizes the laboratory’s financial performance by maximizing efficiency, improving cash collection, and delivering financially accurate and actionable business intelligence.

All digital offerings will be available through a special marketplace, the Digital Ecosystem Store. The store allows users to search for, request a quotation or trial, and download offerings as part of specific subscription models. Offerings available in the store cover cloud-based and locally installed deployments. Due to the collaborative nature of the Digital Ecosystem, customers and patients benefit from an ever-expanding range of digital health offerings.

For more information: www.usa.healthcare.siemens.com

1. The Siemens Healthineers Digital Ecosystem is under development and not commercially available in the U.S. and other countries. If the services are not marketed in countries due to regulatory or other reasons, this service offering cannot be guaranteed.

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 07, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2  The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ve

 The first of three clinical scenarios presented to the panel with final recommendations. Mild features refer to absence of significant pulmonary dysfunction or damage. Pre-test probability is based upon background prevalence of disease and may be further modified by individual’s exposure risk. The absence of resource constraints corresponds to sufficient availability of personnel, personal protective equipment, COVID-19 testing, hospital beds, and/or ventilators with the need to rapidly triage patients. Contextual detail and considerations for imaging with CXR (chest radiography) versus CT (computed tomography) are presented in the text. (Pos=positive, Neg=negative, Mod=moderate). [Although not covered by this scenario and not shown in the figure, in the presence of significant resources constraints, there is no role for imaging of patients with mild features of COVID-19.] Image courtesy of the journal Radiology

News | Coronavirus (COVID-19) | April 07, 2020
April 7, 2020 — A multinational consens...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Chest CT findings of pediatric patients with COVID-19 on transaxial images. (a) Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe

Chest CT findings of pediatric patients with COVID-19 on transaxial images. Male, 2 months old, 2 days after symptom onset. Patchy ground-glass opacities GGO in the right lower lobe. Image courtesy of Radiology: Cardiothoracic Imaging

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Children and teenagers with COVID-19...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

Sonogram taken under rib cage shows liver (grey) with curved diaphragm-lung border (white). Arrows point to vertical B lines (white) demonstrating diseased lung tissue. The more B lines the worse the disease. Healing is measured by reduction in the number of B lines.

News | Coronavirus (COVID-19) | April 06, 2020
April 6, 2020 — Robert L.
Recommended best practices for nuclear imaging departments under the COVIF-19 pandemic have been issues by the ASNC and SNMMI. #COVID19 #ASNC #SNMMI #Coronavirus #SARScov2
News | Coronavirus (COVID-19) | April 03, 2020
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear im
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...